Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Elizabeth Hale Hammond

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 18, 2011
ASCO-CAP guidelines for breast predictive factor testing: an updateM Elizabeth Hale Hammond
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2018
Reply to C. Murray et al and V. Martin et alAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Journal of Oncology Practice|June 20, 2018
HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update SummaryAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Archives of Pathology & Laboratory Medicine|January 4, 2019
In ReplyAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Archives of Pathology & Laboratory Medicine|August 7, 2024
Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast CancerJosef Rüschoff, Alexander Penner, Ian O Ellis, et al.
Archives of Pathology & Laboratory Medicine|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 18, 2011
ASCO-CAP guidelines for breast predictive factor testing: an updateM Elizabeth Hale Hammond
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2018
Reply to C. Murray et al and V. Martin et alAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Journal of Oncology Practice|June 20, 2018
HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update SummaryAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Archives of Pathology & Laboratory Medicine|January 4, 2019
In ReplyAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Archives of Pathology & Laboratory Medicine|August 7, 2024
Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast CancerJosef Rüschoff, Alexander Penner, Ian O Ellis, et al.
Archives of Pathology & Laboratory Medicine|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Pageof 1